Cellular Biomedicine Group

7Feb

CBMG to Present at the 19th BIO CEO & Investor Conference on February 13, 2017

9Jan

Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China

4Jan

Upcoming Presentation at the 9th Annual Biotech Showcase in San Francisco

3Jan

Expansion of Cell Production to Produce CAR-T Therapies

9Dec

Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoinTM

29Nov

CBMG Approved to Commence Phase I Trial for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)

28Nov

CBMG to Present at the 2016 World Stem Cell Summit

14Nov

Appointment of Gang Ji to Board of Directors

9Nov

Q3 Results

9Sep

Results of 2016 AGM